Gilteritinib
Back to searchMolecule Structure
Scientific Name
Gilteritinib
Description of the Drug
Gilteritinib is an AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12141
http://www.drugbank.ca/drugs/DB12141
Brand Name(s)
Not Available
Company Owner(s)
Astellas Pharma Us Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tyrosine-protein kinase receptor UFO | SINGLE PROTEIN | INHIBITOR | CHEMBL4895 |
Tyrosine-protein kinase receptor FLT3 | SINGLE PROTEIN | INHIBITOR | CHEMBL1974 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL282229 | ||
Human Metabolome Database | HMDB0252717 | ||
DrugBank | DB12141 | ||
PubChem: Thomson Pharma | 103775109 | ||
PubChem | 49803313 | ||
Nikkaji | J3.425.284J | ||
PDBe | C6F | ||
BindingDB | 144315 | ||
DrugCentral | 5306 | ||
ChemicalBook | CB82725626 | ||
Guide to Pharmacology | 8708 | ||
rxnorm | XOSPATA | GILTERITINIB FUMARATE | GILTERITINIB |
ChEBI | 145372 | ||
ZINC | ZINC000113476229 |